Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

ClinicalTrials.gov ID: NCT06932263

Public ClinicalTrials.gov record NCT06932263. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIb, Multicentre, Double-blind, Placebo-controlled Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adult Participants With Uncontrolled Asthma on Medium-to High Dose Inhaled Corticosteroids

Study identification

NCT ID: NCT06932263
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: AstraZeneca; Industry
Enrollment: 540 participants

Conditions and interventions

Conditions

Asthma

Interventions

Placebo Drug
Tozorakimab Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 75 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 25, 2025
Primary completion: Jun 23, 2027
Completion: Mar 15, 2028
Last update posted: Apr 8, 2026

2025 – 2028

United States locations

U.S. sites: 51
U.S. states: 25
U.S. cities: 49

Facility	City	State	ZIP	Site status
Research Site	Bakersfield	California	93301	Recruiting
Research Site	Huntington Beach	California	92647	Withdrawn
Research Site	La Mesa	California	91942	Recruiting
Research Site	Newport Beach	California	92663	Recruiting
Research Site	San Jose	California	95117	Recruiting
Research Site	Wilmington	Delaware	19805	Recruiting
Research Site	Cutler Bay	Florida	33189	Suspended
Research Site	Hialeah	Florida	33012	Suspended
Research Site	Hialeah	Florida	33015	Suspended
Research Site	Leesburg	Florida	34748	Withdrawn
Research Site	Miami	Florida	33155	Suspended
Research Site	Miami	Florida	33175	Suspended
Research Site	Orlando	Florida	32819	Suspended
Research Site	Palmetto Bay	Florida	33157	Suspended
Research Site	Tampa	Florida	33607	Suspended
Research Site	Winter Park	Florida	32789	Suspended
Research Site	Boise	Idaho	83706	Withdrawn
Research Site	Indianapolis	Indiana	46268	Recruiting
Research Site	West Des Moines	Iowa	50266	Recruiting
Research Site	Louisville	Kentucky	40218	Recruiting
Research Site	White Marsh	Maryland	21162	Withdrawn
Research Site	Farmington Hills	Michigan	48336	Recruiting
Research Site	Warren	Michigan	48088	Withdrawn
Research Site	St Louis	Missouri	63141	Withdrawn
Research Site	Bellevue	Nebraska	68123	Withdrawn
Research Site	Grand Island	Nebraska	68803	Recruiting
Research Site	Omaha	Nebraska	68134	Recruiting
Research Site	Toms River	New Jersey	08755	Recruiting
Research Site	Maspeth	New York	11378	Recruiting
Research Site	Asheville	North Carolina	28803	Withdrawn
Research Site	Huntersville	North Carolina	28078	Withdrawn
Research Site	Kings Mountain	North Carolina	28086	Recruiting
Research Site	Toledo	Ohio	43617	Recruiting
Research Site	Edmond	Oklahoma	73034	Withdrawn
Research Site	Grants Pass	Oregon	97527	Withdrawn
Research Site	Medford	Oregon	97504	Recruiting
Research Site	Portland	Oregon	97202	Recruiting
Research Site	DuBois	Pennsylvania	15801	Recruiting
Research Site	Philadelphia	Pennsylvania	19140	Recruiting
Research Site	Smithfield	Pennsylvania	15478	Recruiting
Research Site	Rock Hill	South Carolina	29732	Recruiting
Research Site	Knoxville	Tennessee	37919	Recruiting
Research Site	Austin	Texas	78759	Recruiting
Research Site	Forney	Texas	75126	Terminated
Research Site	Kingwood	Texas	77339	Recruiting
Research Site	Tyler	Texas	75708	Withdrawn
Research Site	Victoria	Texas	77901	Recruiting
Research Site	Roy	Utah	84067	Terminated
Research Site	Bellingham	Washington	98225	Terminated
Research Site	Kingwood	West Virginia	26537	Recruiting
Research Site	Milwaukee	Wisconsin	53228	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 157 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06932263, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 8, 2026 · Synced Apr 29, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06932263 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →